TriClip™ TEER

WINNING THE CHALLENGES
OF THE RIGHT HEART

Intentionally designed for the right heart and tricuspid valve.1,2

TriClip™ TEER offers unmatched stability, precision, and control3,* required for the unique challenges of the tricuspid anatomy to achieve sustained, clinically significant improvements in the lives of TR patients.4,5

  1. Significant TR Reduction6
  2. Strong safety profile5,6
  3. Life changing improvements in function and QoL4,5,6
  4. Proven in the largest body of evidence to date4,5

* Based on Abbott simulated horizontal tensile testing.

A STATE OF THE ART Treatment Option for Patients at High Risk for Surgery

TriClip TEER is a low-risk, minimally invasive, non-surgical treatment option for symptomatic patients with severe Tricuspid Regurgitation (TR) who are at high-risk for surgery.

  • Transcatheter beating heart procedure - no cardiopulmonary bypass
  • Allows for real-time positioning and repositioning to optimize TR reduction
  • Femoral venous access
  • Can be used in a standard cath lab or hybrid room
  • No pre-procedural CT required
  • Fast recovery times; many patients go home the next day

Significant TR Reduction with TriClip™ Therapy

See clinical outcomes

MAT-2006554 v4.0 | Item approved for Global OUS use only.

References
  1. Data on file at Abbott. PS2203200
  2. Data on file at Abbott. PS2203401
  3. Testing performed by and data on file at Abbott. RPT2133700
  4. Von Bardeleben RS, Lurz P, Sitges M, et al. Percutaneous edge-to-edge repair for tricuspid regurgitation: 2-year outcomes from the TRILUMINATE trial. Presented at: EuroPCR 2021
  5. Lurz P. Schueler R., Goebel B. et al. Real-world outcomes for tricuspid edge-to-edge repair:  initial 30-day results from the TriClip bRIGHT Study. Presented at: PCR London Valves 2021.  
  6. Lurz P, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardio. 2021;77:229-23
     

Sign up

Receive updates from Abbott Structural Heart

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

YOU ARE ABOUT TO LEAVE
www.structural­heart­solutions.com

You are now leaving www.structuralheartsolutions.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.